Practical Reviews

Survival Is Prolonged in Elderly Patients With Glioblastoma

Key PickKey Reviews are selected for their clinical importance or significance and are marked with a key icon.

Background: Glioblastoma multiforme (GBM) is a lethal disease with limited survival. Patients aged 65 years do particularly badly with survival being inversely proportional to age. Surgery, radiotherapy (RT), and temozolomide chemotherapy (TZ) are the usual methods of therapy. This study compares survival in the RT group versus RT plus TZ group in older patients. Objective: To compare the RT group with RT plus TZ group for survival and also study the subgroup of patients with or wi more...
ABSTRACT VIEW
To view this content, you must be a logged in subscriber to PracticalReviews.com.
Please Login to view this content.